
Download a slideset created by Charles L. Sawyers, MD, and Moshe Talpaz, MD, that reviews the latest data on chronic myeloid leukemia presented at the 2007 Annual Meeting of the American Society of Hematology in Atlanta, Georgia, and the clinical implications.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the differences between tyrosine kinase inhibitors and results of recent studies on their use in chronic myeloid leukemia
- Discuss the clinical implications of data on the use of tyrosine kinase inhibitors in chronic myeloid leukemia
- Relate the role of genetic analyses in determining treatment options for chronic myeloid leukemia